Dendritic cell-based therapeutics for breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2004-01-01 / Breast Dis 2004;20:65-71Thyroglobulin-pulsed human monocyte-derived dendritic cells induce CD4+ T cell activation
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2004-01-01 / Int. J. Mol. Med. 2004 Jan;13(1):33-9DC-based immunotherapy of B-cell malignancies
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2004-01-01 / Cytotherapy 2004;6(1):62-7The immune response to breast cancer, and the case for DC immunotherapy
/in Breast Cancer, Dendritic Cells, International Publications /von 2004-01-01 / Cytotherapy 2004;6(2):154-63
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution